Targeted Genetics to Present at the BIO CEO & Investor 2008 Conference

SEATTLE, WA today announced that H. Stewart Parker, president and chief executive officer of Targeted Genetics Corporation, will present at the 10th Annual BIO CEO & Investor 2008 conference, Monday, February 11th at 2:45 p.m. ET at the Waldorf-Astoria in New York. Ms. Parker will provide a corporate overview and discuss the Company's multiple products in development.

The presentation will be webcast and can be accessed by visiting the "Events" section found on the Homepage of the Company's website at http://www.targetedgenetics.com. Additional information regarding the conference can be accessed at http://ceo.bio.org/opencms/ceo/2008/.

About Targeted Genetics

Targeted Genetics Corporation is a biotechnology company committed to the development of innovative targeted molecular therapies for the prevention and treatment of acquired and inherited diseases with significant unmet medical need. Targeted Genetics' proprietary Adeno-Associated Virus (AAV) technology platform allows it to deliver genes that encode proteins to increase gene function or RNAi to decrease or silence gene function. Targeted Genetics' product development efforts target inflammatory arthritis, AIDS prophylaxis, congestive heart failure and Huntington's disease. To learn more, visit the Company's website at http://www.targetedgenetics.com.

Investor and Media Contacts: Stacie D. Byars Targeted Genetics Corporation 206.521.7392 Carolyn Wang WeissComm Partners 415.225.5050

Tecogen (NASDAQ:TGEN)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024